Early Access — free while we kick the tires
EdgarHawk

FMR LLC

10% Owner

10% Owner

Latest: Insider selling · June 2026

2 filings analyzed · 2 companies · Latest 2026-06-29

Never miss a filing from FMR LLC

Watch this insider and we'll alert you the moment they file — at any company.

Companies

Company Buys Sells Direction
Beam Therapeutics Inc. BEAM 0 2 Net selling
Sana Biotechnology, Inc. SANA 0 4 Net selling

Activity

June 2026
2026-06-29 Beam Therapeutics Inc. BEAM
high
Sell
284,860 shares
$10,039,492
Significance 7/10

FMR LLC (10% Owner) sells 284.9K shares of BEAM for $10.0M at blended avg $35.24; -25.0% reduction in holdings

FMR LLC executed 2 separate sales totaling 284,860 shares for $10,039,491.52 on June 25–26, 2026, reducing its stake from 1,139,443 to 854,583 shares (a -25.0% net change vs pre-transaction holdings). The blended average price of $35.24 sits near the current price of $35.06, within the 52-week range of $15.60–$36.88, and only 4.9% below the 52-week high, suggesting the insider sold into a period of relative strength (stock is +47.1% over 90 days and +6.5% over 30 days). FMR's prior 4 trades at BEAM (all in February 2024) were each well-timed at the 90-day mark, with all showing negative 90-day returns after the sells; however, this track record is specific to BEAM and does not automatically predict this transaction's outcome. Notably, BEAM remains unprofitable (net income $-94.3M over the latest full fiscal year), though revenue showed strong 120% annual growth to $31.7M in the latest quarter, which underscores the tension between growth momentum and fundamental losses that may be driving the disposition.

January 2025
high
Sell
290,912 shares
$1,887,320
Significance 6/10

FMR LLC sold 290,912 shares for $1,887,319.52 at $6.49 avg; stock down 67.5% from 52-week high at $3.66

FMR LLC, a 10% owner, executed 4 separate sales totaling 290,912 shares for $1,887,319.52 on January 8, 2025, reducing holdings from 4,832,423 shares to 4,541,511 shares (a 6.0% reduction). The blended average sale price was $6.49, but the stock now trades at $3.66, representing a 43.6% decline from the transaction price. The company is unprofitable with a net loss of $-59,924,000.00 over the most recent full fiscal year. Across FMR LLC's cross-ticker insider trading history, prior sales show a 90-day well-timed rate of 100.00%, indicating the insider's prior sell decisions were followed by stock declines. This sale occurred as the stock trades severely depressed relative to its 52-week high of $11.27 and contrasts with recent momentum (+56.4% over 30 days).

Related insiders